Abstract
Sleeve gastrectomy (SG) is deemed a refluxogenic operation but with a low incidence of postoperative Barrett´s esophagus (BE). We aimed to shed some light on the potential paradox of the weak association between SG, BE and esophageal adenocarcinoma (EAC). The high incidence of GERD after SG is not followed by an increased rate of BE and EAC, as these rates are similar to the general population. We hypothesized that this paradox may occur due to a difference in the gastro-esophageal reflux composition secondary to a lower content of bile, to a decrease in inflammation due to weight loss and hormonal changes, and to acquisition of healthier habits such as exercise, smoking cessation, and better eating behavior.
Graphical Abstract
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11695-023-06599-y/MediaObjects/11695_2023_6599_Figa_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-023-06599-y/MediaObjects/11695_2023_6599_Fig1_HTML.png)
Similar content being viewed by others
References
Valezi AC, Herbella FAM, Schlottmann F, et al. Gastroesophageal reflux disease in obese patients. J Laparoendosc Adv Surg Tech A. 2018;28(8):949–52. https://doi.org/10.1089/lap.2018.0395.
Chang P, Friedenberg F. Obesity and GERD. Gastroenterol Clin N Am. 2014;43:161–73.
Herbella FA, Sweet MP, Tedesco P, Nipomnick I, Patti MG. Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment. J Gastrointest Surg. 2007;11(3):286–90. https://doi.org/10.1007/s11605-007-0097-z.
Schlottmann F, Masrur MA, Herbella FAM, et al. Roux-en-Y gastric bypass and gastroesophageal reflux disease: an infallible anti-reflux operation? Obes Surg. 2022;32(7):2481–3. https://doi.org/10.1007/s11695-022-06083-z.
Patti MG, Schlottmann F. Gastroesophageal reflux after sleeve gastrectomy. JAMA Surg. 2018;153(12):1147–8. https://doi.org/10.1001/jamasurg.2018.2437.
Nadaleto BF, Herbella FA, Patti MG. Gastroesophageal reflux disease in the obese: pathophysiology and treatment. Surgery. 2016;159(2):475–86. https://doi.org/10.1016/j.surg.2015.04.034.
Gagner M. Is sleeve gastrectomy always an absolute contraindication in patients with Barrett’s? Obes Surg. 2016;26(4):715–7. https://doi.org/10.1007/s11695-015-1983-1.
Yeung KTD, Penney N, Ashrafian L, et al. Does sleeve gastrectomy expose the distal esophagus to severe reflux?: a systematic review and meta-analysis. Ann Surg. 2020;271(2):257–65. https://doi.org/10.1097/SLA.0000000000003275.
Georgia D, Stamatina T, Maria N, et al. 24-h multichannel intraluminal impedance PH-metry 1 year after laparocopic sleeve gastrectomy: an objective assessment of gastroesophageal reflux disease. Obes Surg. 2017;27(3):749–53. https://doi.org/10.1007/s11695-016-2359-x.
Cook MB, Thrift AP. Epidemiology of Barrett’s esophagus and esophageal adenocarcinoma: implications for screening and surveillance. Gastrointest Endosc Clin N Am. 2021;31(1):1–26. https://doi.org/10.1016/j.giec.2020.08.001.
Marques de Sá I, Marcos P, Sharma P, et al. The global prevalence of Barrett’s esophagus: a systematic review of the published literature. United Eur Gastroenterol J. 2020;8(9):1086–105. https://doi.org/10.1177/2050640620939376.
Ozeki KA, Tran SA, Cheung R, et al. Preoperative endoscopic findings in veterans undergoing bariatric surgery: prevalence and predictors of Barrett’s esophagus. Obes Surg. 2020;30(2):657–63. https://doi.org/10.1007/s11695-019-04234-3.
Braghetto I, Csendes A. Prevalence of Barrett’s esophagus in bariatric patients undergoing sleeve gastrectomy. Obes Surg. 2016;26(4):710–4. https://doi.org/10.1007/s11695-015-1574-1.
Genco A, Castagneto-Gissey L, Lorenzo M, et al. Esophageal adenocarcinoma after sleeve gastrectomy: actual or potential threat? Italian series and literature review. Surg Obes Relat Dis. 2021;17(5):848–54. https://doi.org/10.1016/j.soard.2020.11.023.
Schlottmann F, Dreifuss NH, Patti MG. Obesity and esophageal cancer: GERD, Barrett’s esophagus, and molecular carcinogenic pathways. Expert Rev Gastroenterol Hepatol. 2020;14(6):425–33. https://doi.org/10.1080/17474124.2020.1764348.
ASGE STANDARDS OF PRACTICE COMMITTEE, Qumseya B, Sultan S, et al. ASGE guideline on screening and surveillance of Barrett’s esophagus. Gastrointest Endosc. 2019;90(3):335-359.e2. https://doi.org/10.1016/j.gie.2019.05.012.
Elkassem S. Gastroesophageal reflux disease, esophagitis, and Barrett’s esophagus 3 to 4 years post sleeve gastrectomy. Obes Surg. 2021;31(12):5148–55. https://doi.org/10.1007/s11695-021-05688-0.
Qumseya BJ, Qumsiyeh Y, Ponniah SA, et al. Barrett’s esophagus after sleeve gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93(2):343-352.e2. https://doi.org/10.1016/j.gie.2020.08.008.
Salminen P, Grönroos S, Helmiö M, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS Randomized Clinical Trial. JAMA Surg. 2022;e222229. https://doi.org/10.1001/jamasurg.2022.2229.
Fisher OM, Chan DL, Talbot ML, et al. Barrett’s Oesophagus and bariatric/metabolic surgery-IFSO 2020 position statement. Obes Surg. 2021;31(3):915–34. https://doi.org/10.1007/s11695-020-05143-6.
Bevilacqua LA, Obeid NR, Yang J, et al. Incidence of GERD, esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma after bariatric surgery. Surg Obes Relat Dis. 2020;16(11):1828–36. https://doi.org/10.1016/j.soard.2020.06.016.
Felsenreich DM, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017;27(12):3092–101. https://doi.org/10.1007/s11695-017-2748-9.
Felsenreich DM, Ladinig LM, Beckerhinn P, et al. Update: 10 years of sleeve gastrectomy-the first 103 patients. Obes Surg. 2018;28(11):3586–94. https://doi.org/10.1007/s11695-018-3399-1.
Soricelli E, Casella G, Baglio G, et al. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy. Surg Obes Relat Dis. 2018;14(6):751–6. https://doi.org/10.1016/j.soard.2018.02.008.
Braghetto I, Gonzalez P, Lovera C, et al. Duodenogastric biliary reflux assessed by scintigraphic scan in patients with reflux symptoms after sleeve gastrectomy: preliminary results. Surg Obes Relat Dis. 2019;15(6):822–6. https://doi.org/10.1016/j.soard.2019.03.034.
Sebastianelli L, Benois M, Vanbiervliet G, et al. Systematic endoscopy 5 years after sleeve gastrectomy results in a high rate of Barrett’s esophagus: results of a multicenter study. Obes Surg. 2019;29(5):1462–9. https://doi.org/10.1007/s11695-019-03704-y.
Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13(4):568–74. https://doi.org/10.1016/j.soard.2016.11.029.
Braghetto I, Korn O. Late esophagogastric anatomic and functional changes after sleeve gastrectomy and its clinical consequences with regards to gastroesophageal reflux disease. Dis Esophagus. 2019;32(6):doz020. https://doi.org/10.1093/dote/doz020.
Csendes A, Orellana O, Martínez G, et al. Clinical, endoscopic, and histologic findings at the distal esophagus and stomach before and late (10.5 years) after laparoscopic sleeve gastrectomy: results of a prospective study with 93% follow-up. Obes Surg. 2019;29(12):3809–17. https://doi.org/10.1007/s11695-019-04054-5.
Al Sabah S, AlWazzan A, AlGhanim K, et al. Does Laparoscopic Sleeve Gastrectomy lead to Barrett’s esophagus, 5-year esophagogastroduodenoscopy findings: a retrospective cohort study. Ann Med Surg (Lond). 2021;31(62):446–9. https://doi.org/10.1016/j.amsu.2021.01.096.
Benvenga R, Roussel J, Cohen R, et al. Long-term endoscopic follow-up after sleeve gastrectomy. J Visc Surg. 2022;159(1):39–42. https://doi.org/10.1016/j.jviscsurg.2020.11.003.
Lallemand L, Duchalais E, Musquer N, et al. Does sleeve gastrectomy increase the risk of Barret’s esophagus? Obes Surg. 2021;31(1):101–10. https://doi.org/10.1007/s11695-020-04875-9.
Migaczewski M, Czerwińska A, Rubinkiewicz M, et al. The prevalence of, and risk factors for, Barrett’s oesophagus after sleeve gastrectomy. Wideochir Inne Tech Maloinwazyjne. 2021;16(4):710–4. https://doi.org/10.5114/wiitm.2021.107776.
Salminen P, Grönroos S, Helmiö M, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS Randomized Clinical Trial. JAMA Surg. 2022;157(8):656–66. https://doi.org/10.1001/jamasurg.2022.2229.
Leslie D, Wise E, Sheka A, et al. gastroesophageal reflux disease outcomes after vertical sleeve gastrectomy and gastric bypass. Ann Surg. 2021;274(4):646–53. https://doi.org/10.1097/SLA.0000000000005061.
Genco A, Castagneto-Gissey L, Gualtieri L, et al. GORD and Barrett’s oesophagus after bariatric procedures: multicentre prospective study. Br J Surg. 2021;108(12):1498–505. https://doi.org/10.1093/bjs/znab330.
Felsenreich DM, Artemiou E, Wintersteller L, et al. Fifteen years after sleeve gastrectomy: gastroscopies, manometries, and 24-h pH-metries in a long-term follow-up: a multicenter study. Obes Facts. 2022;15(5):666–73. https://doi.org/10.1159/000526170.
Platt KD, Schulman AR. Screening for Barrett’s esophagus after sleeve gastrectomy. Gastrointest Endosc. 2021;93(2):353–5. https://doi.org/10.1016/j.gie.2020.09.017.
Huang J, Koulaouzidis A, Marlicz W, et al. Global burden, risk factors, and trends of esophageal cancer: an analysis of cancer registries from 48 countries. Cancers (Basel). 2021;13(1):141. https://doi.org/10.3390/cancers13010141.
Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(11):1399-1412.e7. https://doi.org/10.1016/j.cgh.2013.05.009.
Gagner M. Alarmists at the gates: esophageal adenocarcinoma after sleeve gastrectomy is not different than with other bariatric/metabolic surgeries. Obes Surg. 2022;32(7):2457–9. https://doi.org/10.1007/s11695-022-05992-3.).
Chen W, Wang Y, Zhu J, et al. Esophagogastric cancer after sleeve gastrectomy: a systematic review of case reports. Cancer Manag Res. 2021;15(13):3327–34. https://doi.org/10.2147/CMAR.S303590.
Parmar C, Pouwels S. Oesophageal and gastric cancer after bariatric surgery: an up-to-date systematic sco** review of literature of 324 cases. Obes Surg. 2022;32(12):3854–62. https://doi.org/10.1007/s11695-022-06304-5.
Ahmed MA, Zhang Z, Ramamoorthy V, Saxena A, Rubens M, Appunni S, McGranaghan P, Jalal AH, Veledar E. Difference in 30-day readmission rates after laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass: a propensity score matched study using ACS NSQIP data (2015–2019). Obes Surg. 2023. https://doi.org/10.1007/s11695-022-06446-6.
Shen Q, Chen H. A novel risk classification system based on the eighth edition of TNM frameworks for esophageal adenocarcinoma patients: a deep learning approach. Front Oncol. 2022;12:887841. https://doi.org/10.3389/fonc.2022.887841.
O’Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, Crosthwaite G, Brown W. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29(1):3–14. https://doi.org/10.1007/s11695-018-3525-0.
Emile SH, Ghareeb W, Elfeki H, et al. Development and validation of an artificial intelligence-based model to predict gastroesophageal reflux disease after sleeve gastrectomy. Obes Surg. 2022;32(8):2537–47. https://doi.org/10.1007/s11695-022-06112-x.
Eldredge TA, Bills M, Ting YY, et al. Once in a bile — the incidence of bile reflux post-bariatric surgery. Obes Surg. 2022;32:1428–38. https://doi.org/10.1007/s11695-022-05977-2.
Chern TY, Chan DL, Maani J, et al. High-resolution impedance manometry and 24-hour multichannel intraluminal impedance with pH testing before and after sleeve gastrectomy: de novo reflux in a prospective series. Surg Obes Relat Dis. 2021;17(2):329–37. https://doi.org/10.1016/j.soard.2020.09.030.
Herbella FA. Critical analysis of esophageal multichannel intraluminal impedance monitoring 20 years later. ISRN Gastroenterol. 2012;2012:903240. https://doi.org/10.5402/2012/903240.
Cantay H, Binnetoglu K, Erdogdu UE, Firat YD, Cayci HM. Comparison of short- and long-term outcomes of bariatric surgery methods: a retrospective study. Medicine (Baltimore). 2022;101(38):e30679. https://doi.org/10.1097/MD.0000000000030679.
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-en-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32. https://doi.org/10.1007/s11695-015-1869-2.
Parsa N, Kahn A. Chapter 4 - Impact of obesity on Barrett’s esophagus and esophageal adenocarcinoma. Obesity and Esophageal Disorders. Academic Press; 2022, Pages 49–59. ISBN 9780323983655. https://doi.org/10.1016/B978-0-323-98365-5.00001-2.
Lautenbach A, Stoll F, Mann O, et al. Long-term improvement of chronic low-grade inflammation after bariatric surgery. Obes Surg. 2021;31:2913–20. https://doi.org/10.1007/s11695-021-05315-y.
Turner L, Santosa S. Putting ATM to BED: how adipose tissue macrophages are affected by bariatric surgery, exercise, and dietary fatty acids. Adv Nutr. 2021;12(5):1893–910. https://doi.org/10.1093/advances/nmab011.
Salman AA, Sultan AAEA, Abdallah A, et al. Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels. J Gastroenterol Hepatol. 2020;35(10):1769–73. https://doi.org/10.1111/jgh.15029.
Aminian A, Wilson R, Al-Kurd A, et al. Association of bariatric surgery with cancer risk and mortality in adults with obesity. JAMA. 2022;327(24):2423–33. https://doi.org/10.1001/jama.2022.9009.
Nikiforova I, Barnea R, Azulai S, et al. Analysis of the association between eating behaviors and weight loss after laparoscopic sleeve gastrectomy. Obes Facts. 2019;12(6):618–31. https://doi.org/10.1159/000502846.
Wolvers PJD, Ayubi O, Bruin SC, et al. Smoking behaviour and beliefs about smoking cessation after bariatric surgery. Obes Surg. 2021;31:239–49. https://doi.org/10.1007/s11695-020-04907-4.
Herring LY, Stevinson C, Davies MJ, et al. Changes in physical activity behaviour and physical function after bariatric surgery: a systematic review and meta-analysis. Obes Rev. 2016;17(3):250–61. https://doi.org/10.1111/obr.12361.
Hidayat K, Zhou HJ, Shi BM. Influence of physical activity at a young age and lifetime physical activity on the risks of 3 obesity-related cancers: systematic review and meta-analysis of observational studies. Nutr Rev. 2020;78(1):1–18. https://doi.org/10.1093/nutrit/nuz024.
Rebecchi F, Allaix ME, Giaccone C, et al. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a physiopathologic evaluation. Ann Surg. 2014;260(5):909–14. https://doi.org/10.1097/SLA.0000000000000967. (discussion 914-5).
Author information
Authors and Affiliations
Contributions
RO: acquisition of data, data analysis, drafting the article, final approval of the version to be published.
FAMH: Conception and design, acquisition of data, data analysis, drafting the article, final approval of the version to be published.
RCK: Conception and design, final approval of the version to be published.
MGP: Conception and design, review for intellectual content, final approval of the version to be published.
Corresponding author
Ethics declarations
For this type of study formal consent is not required.
Conflicts of Interest
The authors have no conflict of interest to declare.
Disclosures
The authors have nothing to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
IRB is waived for this type of manuscript.
There is no additional data available.
Keypoints
• Sleeve gastrectomy is deemed a refluxogenic operation but with a low incidence of postoperative Barrett´s esophagus.
• Esophageal adenocarcinoma, another consequence of gastroesophageal reflux disease, is also rare after sleeve gastrectomy.
• This paradox may occur due to a difference in the gastroesophageal reflux composition secondary to a lower content of bile, to a decrease in inflammation due to weight loss and hormonal changes, and to acquisition of healthier habits such as exercise, smoking cessation, and better eating behavior.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Orlow, R., Herbella, F.A.M., Katayama, R.C. et al. Insights into the Paradox of the Weak Association Between Sleeve Gastrectomy and Barrett’s Esophagus. OBES SURG 33, 1910–1915 (2023). https://doi.org/10.1007/s11695-023-06599-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-06599-y